Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure

Critically ill patients with COVID continue to die at an alarming rate—a recent case series published in JAMA reported 88.1% mortality for patients requiring mechanical ventilation in a large health care system in New York [5]. At this time, in the absence of more specific labs, the clinician’s chal...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) England), 2020-05, Vol.24 (1), p.226-226, Article 226
Main Authors: Honore, Patrick M, Mugisha, Aude, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David
Format: Article
Language:English
Subjects:
Adult respiratory distress syndrome
Betacoronavirus
Care and treatment
Coronavirus
Coronavirus Infections
Coronaviruses
COVID-19
Critical care
Health aspects
Humans
Investigations
Letter
Pandemics
Plasma
Plasma Exchange
Plasma exchange (Therapeutics)
Pneumonia, Viral
SARS-CoV-2
Sepsis
Septic shock
Shock, Septic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3
cites cdi_FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3
container_end_page 226
container_issue 1
container_start_page 226
container_title Critical care (London, England)
container_volume 24
creator Honore, Patrick M
Mugisha, Aude
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
description Critically ill patients with COVID continue to die at an alarming rate—a recent case series published in JAMA reported 88.1% mortality for patients requiring mechanical ventilation in a large health care system in New York [5]. At this time, in the absence of more specific labs, the clinician’s challenge of evaluating patients and making the most appropriate treatment decisions must mainly be guided by the clinical parameters, as determined by currently available resources and evidence. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.
doi_str_mv 10.1186/s13054-020-02943-1
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_34b31a93dcef48df8f0d7c6ca5920d2a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A627456826</galeid><doaj_id>oai_doaj_org_article_34b31a93dcef48df8f0d7c6ca5920d2a</doaj_id><sourcerecordid>A627456826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEoqXwB1ggS2zYpPgdhwVSNbxGqtRNQewsj309kyFjBzsBuuKv48mUwiBkWb6yv3Psa52qekrwOSFKvsyEYcFrTHGZLWc1uVedEi5lLXH7-X6pmeS1EkycVI9y3mJMGiXZw-qEUU44J81p9fN6A8kMMI2dRUNv8s4g-GE3JqwBmYwMSrGcBUDjDN6gLqAMwx7Pm2i_IBPcDIaiGyB1Owij6dGYwIz7GvmY0OLq0_JNTdpX6HuxTYBCHFGeEjyuHnjTZ3hyu55VH9-9vV58qC-v3i8XF5e1FZKNdUtEYw1hgiiqfGlCmYYp6QkmnraEOc6E59Zhu3JcNJgJoMqtGuvBN9h7dlYtD74umq0eyjNNutHRdHreiGmtTSpN9aAZXzFiWuYseK6cVx67xkprREuxo6Z4vT54DdNqBwULYzL9kenxSeg2eh2_6YZSxRkvBi9uDVL8OkEe9a7LFvreBIhT1pTjMrjksqDP_0G3cUqhfNVMUc4po3-otSkNdMHHcq_dm-oLSRsupKJ7r_P_UGU42HU2BvBd2T8S0IPApphzAn_XI8F6H0F9iKAuEdRzBDUpomd__86d5Hfm2C--hNXo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404244232</pqid></control><display><type>article</type><title>Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure</title><source>PubMed Central Free</source><source>ProQuest - Publicly Available Content Database</source><source>Coronavirus Research Database</source><creator>Honore, Patrick M ; Mugisha, Aude ; Kugener, Luc ; Redant, Sebastien ; Attou, Rachid ; Gallerani, Andrea ; De Bels, David</creator><creatorcontrib>Honore, Patrick M ; Mugisha, Aude ; Kugener, Luc ; Redant, Sebastien ; Attou, Rachid ; Gallerani, Andrea ; De Bels, David</creatorcontrib><description>Critically ill patients with COVID continue to die at an alarming rate—a recent case series published in JAMA reported 88.1% mortality for patients requiring mechanical ventilation in a large health care system in New York [5]. At this time, in the absence of more specific labs, the clinician’s challenge of evaluating patients and making the most appropriate treatment decisions must mainly be guided by the clinical parameters, as determined by currently available resources and evidence. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.</description><identifier>ISSN: 1364-8535</identifier><identifier>EISSN: 1466-609X</identifier><identifier>EISSN: 1364-8535</identifier><identifier>EISSN: 1366-609X</identifier><identifier>DOI: 10.1186/s13054-020-02943-1</identifier><identifier>PMID: 32414417</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult respiratory distress syndrome ; Betacoronavirus ; Care and treatment ; Coronavirus ; Coronavirus Infections ; Coronaviruses ; COVID-19 ; Critical care ; Health aspects ; Humans ; Investigations ; Letter ; Pandemics ; Plasma ; Plasma Exchange ; Plasma exchange (Therapeutics) ; Pneumonia, Viral ; SARS-CoV-2 ; Sepsis ; Septic shock ; Shock, Septic</subject><ispartof>Critical care (London, England), 2020-05, Vol.24 (1), p.226-226, Article 226</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3</citedby><cites>FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228434/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2404244232?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32414417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Honore, Patrick M</creatorcontrib><creatorcontrib>Mugisha, Aude</creatorcontrib><creatorcontrib>Kugener, Luc</creatorcontrib><creatorcontrib>Redant, Sebastien</creatorcontrib><creatorcontrib>Attou, Rachid</creatorcontrib><creatorcontrib>Gallerani, Andrea</creatorcontrib><creatorcontrib>De Bels, David</creatorcontrib><title>Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure</title><title>Critical care (London, England)</title><addtitle>Crit Care</addtitle><description>Critically ill patients with COVID continue to die at an alarming rate—a recent case series published in JAMA reported 88.1% mortality for patients requiring mechanical ventilation in a large health care system in New York [5]. At this time, in the absence of more specific labs, the clinician’s challenge of evaluating patients and making the most appropriate treatment decisions must mainly be guided by the clinical parameters, as determined by currently available resources and evidence. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.</description><subject>Adult respiratory distress syndrome</subject><subject>Betacoronavirus</subject><subject>Care and treatment</subject><subject>Coronavirus</subject><subject>Coronavirus Infections</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Critical care</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Investigations</subject><subject>Letter</subject><subject>Pandemics</subject><subject>Plasma</subject><subject>Plasma Exchange</subject><subject>Plasma exchange (Therapeutics)</subject><subject>Pneumonia, Viral</subject><subject>SARS-CoV-2</subject><subject>Sepsis</subject><subject>Septic shock</subject><subject>Shock, Septic</subject><issn>1364-8535</issn><issn>1466-609X</issn><issn>1364-8535</issn><issn>1366-609X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkktv1DAUhSMEoqXwB1ggS2zYpPgdhwVSNbxGqtRNQewsj309kyFjBzsBuuKv48mUwiBkWb6yv3Psa52qekrwOSFKvsyEYcFrTHGZLWc1uVedEi5lLXH7-X6pmeS1EkycVI9y3mJMGiXZw-qEUU44J81p9fN6A8kMMI2dRUNv8s4g-GE3JqwBmYwMSrGcBUDjDN6gLqAMwx7Pm2i_IBPcDIaiGyB1Owij6dGYwIz7GvmY0OLq0_JNTdpX6HuxTYBCHFGeEjyuHnjTZ3hyu55VH9-9vV58qC-v3i8XF5e1FZKNdUtEYw1hgiiqfGlCmYYp6QkmnraEOc6E59Zhu3JcNJgJoMqtGuvBN9h7dlYtD74umq0eyjNNutHRdHreiGmtTSpN9aAZXzFiWuYseK6cVx67xkprREuxo6Z4vT54DdNqBwULYzL9kenxSeg2eh2_6YZSxRkvBi9uDVL8OkEe9a7LFvreBIhT1pTjMrjksqDP_0G3cUqhfNVMUc4po3-otSkNdMHHcq_dm-oLSRsupKJ7r_P_UGU42HU2BvBd2T8S0IPApphzAn_XI8F6H0F9iKAuEdRzBDUpomd__86d5Hfm2C--hNXo</recordid><startdate>20200515</startdate><enddate>20200515</enddate><creator>Honore, Patrick M</creator><creator>Mugisha, Aude</creator><creator>Kugener, Luc</creator><creator>Redant, Sebastien</creator><creator>Attou, Rachid</creator><creator>Gallerani, Andrea</creator><creator>De Bels, David</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200515</creationdate><title>Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure</title><author>Honore, Patrick M ; Mugisha, Aude ; Kugener, Luc ; Redant, Sebastien ; Attou, Rachid ; Gallerani, Andrea ; De Bels, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult respiratory distress syndrome</topic><topic>Betacoronavirus</topic><topic>Care and treatment</topic><topic>Coronavirus</topic><topic>Coronavirus Infections</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Critical care</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Investigations</topic><topic>Letter</topic><topic>Pandemics</topic><topic>Plasma</topic><topic>Plasma Exchange</topic><topic>Plasma exchange (Therapeutics)</topic><topic>Pneumonia, Viral</topic><topic>SARS-CoV-2</topic><topic>Sepsis</topic><topic>Septic shock</topic><topic>Shock, Septic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Honore, Patrick M</creatorcontrib><creatorcontrib>Mugisha, Aude</creatorcontrib><creatorcontrib>Kugener, Luc</creatorcontrib><creatorcontrib>Redant, Sebastien</creatorcontrib><creatorcontrib>Attou, Rachid</creatorcontrib><creatorcontrib>Gallerani, Andrea</creatorcontrib><creatorcontrib>De Bels, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><jtitle>Critical care (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Honore, Patrick M</au><au>Mugisha, Aude</au><au>Kugener, Luc</au><au>Redant, Sebastien</au><au>Attou, Rachid</au><au>Gallerani, Andrea</au><au>De Bels, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure</atitle><jtitle>Critical care (London, England)</jtitle><addtitle>Crit Care</addtitle><date>2020-05-15</date><risdate>2020</risdate><volume>24</volume><issue>1</issue><spage>226</spage><epage>226</epage><pages>226-226</pages><artnum>226</artnum><issn>1364-8535</issn><eissn>1466-609X</eissn><eissn>1364-8535</eissn><eissn>1366-609X</eissn><abstract>Critically ill patients with COVID continue to die at an alarming rate—a recent case series published in JAMA reported 88.1% mortality for patients requiring mechanical ventilation in a large health care system in New York [5]. At this time, in the absence of more specific labs, the clinician’s challenge of evaluating patients and making the most appropriate treatment decisions must mainly be guided by the clinical parameters, as determined by currently available resources and evidence. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>32414417</pmid><doi>10.1186/s13054-020-02943-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1364-8535
ispartof Critical care (London, England), 2020-05, Vol.24 (1), p.226-226, Article 226
issn 1364-8535
1466-609X
1364-8535
1366-609X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_34b31a93dcef48df8f0d7c6ca5920d2a
source PubMed Central Free; ProQuest - Publicly Available Content Database; Coronavirus Research Database
subjects Adult respiratory distress syndrome
Betacoronavirus
Care and treatment
Coronavirus
Coronavirus Infections
Coronaviruses
COVID-19
Critical care
Health aspects
Humans
Investigations
Letter
Pandemics
Plasma
Plasma Exchange
Plasma exchange (Therapeutics)
Pneumonia, Viral
SARS-CoV-2
Sepsis
Septic shock
Shock, Septic
title Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A23%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20plasma%20exchange%20as%20a%20routine%20therapy%20in%20septic%20shock%20and%20as%20an%20experimental%20treatment%20for%20COVID-19:%20we%20are%20not%20sure&rft.jtitle=Critical%20care%20(London,%20England)&rft.au=Honore,%20Patrick%20M&rft.date=2020-05-15&rft.volume=24&rft.issue=1&rft.spage=226&rft.epage=226&rft.pages=226-226&rft.artnum=226&rft.issn=1364-8535&rft.eissn=1466-609X&rft_id=info:doi/10.1186/s13054-020-02943-1&rft_dat=%3Cgale_doaj_%3EA627456826%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c563t-9157ca1351828f8638a7386f101f2913d435f4cd0cbd457035e28db7cfef70ff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2404244232&rft_id=info:pmid/32414417&rft_galeid=A627456826&rfr_iscdi=true